Gurunathan et al.
2020
Antiviral potential of nanoparticles—can nanoparticles fight against coronaviruses?
PH12012502425A1
(en )
2013-07-08
The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer
EP2433622B1
(en )
2014-04-23
Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
Yang et al.
2021
Nanotechnology advances in pathogen-and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control
JP2009535352A5
(uk )
2010-06-03
EA201171376A1
(ru )
2012-05-30
Производные тиено[2,3-b]пиридина в качестве ингибиторов репликации вируса
Ramezankhani et al.
2020
Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
EA037430B1
(ru )
2021-03-26
Противовирусное иммунотропное средство для лечения орви
Haddad et al.
2022
A comprehensive review on the efficacy of several pharmacologic agents for the treatment of COVID-19
Chopra et al.
2013
Liposomes as nanocarriers for anti-HIV therapy
Ashaolu et al.
2021
Potential “biopeptidal” therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs
EA201101035A1
(ru )
2012-02-28
Новый конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем
Koudstaal et al.
2009
Pre-and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir
Tarbet et al.
2014
A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses
Redman et al.
2018
Pharmacokinetic and chemical synthesis optimization of a potent D-peptide HIV entry inhibitor suitable for extended-release delivery
Chen et al.
2020
Antiviral nanoagents: More attention and effort needed?
de M Ribeiro et al.
2020
The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic
Durán et al.
2016
Nanobiotechnology solutions against Aedes aegypti
RU2448692C2
(ru )
2012-04-27
Фармацевтические соли аминобицикло[2.2.1]гептанов как ингибиторы транскрипционного фактора nf-kb с противовирусной активностью (варианты) и их применение
Aderibigbe
2017
Polymeric therapeutic delivery systems for the treatment of infectious diseases
Shankaran et al.
2010
Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy
TH133837A
(uk )
2014-05-19
AMOL et al.
2020
Role of Rasayan churna in outbreak of COVID-19 as preventive and curative aspect
AU2005244826B2
(en )
2010-07-29
Treatment or prevention of respiratory viral infections with immunomodulator compounds
US11724077B2
(en )
2023-08-15
Therapeutic swabs for treating upper respiratory infections